focus -WSS

focus

author：Wikipedia 2025-09-27 23:02:08 - browse：3581

Several amyloid plaques forming between neurons in a brain — Adobe

Expert advisers to the Food and Drug Administration on Friday voted unanimously in favor of expanding the approval of Leqembi, an Alzheimer’s disease treatment from Eisai and Biogen, further clearing the way for what could be the first widely available medicine that delays the disease’s progress.

The group voted 6-0 that an 1,800-patient study of Leqembi confirmed its benefits for patients in the early stages of Alzheimer’s, recommending the FDA widen the drug’s limited approval. The agency, which is not required to follow the suggestions of its advisers, is expected to make a final decision on Leqembi by July 6.

“I thought the clinical results were robust,” said Merit Cudkowicz, a neurologist from Massachusetts General Hospital and one of the experts invited to review Leqembi.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： I learned firsthand about improving diversity in clinical trials

Wikipedia

WSS

Awakening the world to the whoosh: A patient's crusade

Election results set back Medicaid expansion plans

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

Trump used to be more articulate. What could explain the change?

Failure, not just success, should guide future doctors

Sweden knocks USA out of World Cup in penalty kicks

leisure time

focus

knowledge

United colonoscopy coverage change 'may cost lives,' doctors say

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

23andMe had bad news about my health. I wish a person had delivered it

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

BioMarin wins approval for gene therapy to treat hemophilia A

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

As demand for Covid shots wanes, Moderna seeks its next success

Indian pharmaceutical industry in denial over drug

Sports medicine is finally prioritizing gender equality

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

leisure time

Judge in Trump's classified documents case questions use of out

Awakening the world to the whoosh: A patient's crusade

Pennsylvania man bitten on the head by bear during attack in his garage

Doctors push to include dialysis machines in emergency stockpile

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

Slovenia has suffered its worst

Wikipedia

hotspot

leisure time

leisure time